Endocrinologists review the evidence regarding how to assess perimenopausal and postmenopausal hCG elevation and provide a protocol for treating hCG elevation in postmenopausal women.
Patients Will Soon Have an Additional Option When New Osteoporosis Treatment Hits Market
Romosozumab-aqqg may give postmenopausal women an additional option for osteoporosis treatment when other medications are contraindicated. Women’s health specialist Holly Thacker, MD, explains the benefits and potential risks of this new regimen.